224 related articles for article (PubMed ID: 29120412)
1. Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.
Chu YY; Ko CY; Wang SM; Lin PI; Wang HY; Lin WC; Wu DY; Wang LH; Wang JM
Cell Death Dis; 2017 Nov; 8(11):e3167. PubMed ID: 29120412
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex.
Ko CY; Hsu HC; Shen MR; Chang WC; Wang JM
J Biol Chem; 2008 Nov; 283(45):30919-32. PubMed ID: 18753137
[TBL] [Abstract][Full Text] [Related]
3. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
4. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
[TBL] [Abstract][Full Text] [Related]
5. Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a.
Chu YY; Ko CY; Wang WJ; Wang SM; Gean PW; Kuo YM; Wang JM
Mol Neurobiol; 2016 Aug; 53(6):4173-4188. PubMed ID: 26208701
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
8. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
9. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.
Zheng L; Chen Y; Ye L; Jiao W; Song H; Mei H; Li D; Yang F; Li H; Huang K; Tong Q
Sci Rep; 2017 Aug; 7(1):8967. PubMed ID: 28827574
[TBL] [Abstract][Full Text] [Related]
10. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
12. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
13. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance.
Hendrickson DG; Hogan DJ; Herschlag D; Ferrell JE; Brown PO
PLoS One; 2008 May; 3(5):e2126. PubMed ID: 18461144
[TBL] [Abstract][Full Text] [Related]
14. HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
Li CF; Tsai HH; Ko CY; Pan YC; Yen CJ; Lai HY; Yuh CH; Wu WC; Wang JM
Mol Cancer Ther; 2015 Nov; 14(11):2623-33. PubMed ID: 26358750
[TBL] [Abstract][Full Text] [Related]
15. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.
Chuang CH; Wang WJ; Li CF; Ko CY; Chou YH; Chuu CP; Cheng TL; Wang JM
Cell Death Dis; 2014 May; 5(5):e1220. PubMed ID: 24810056
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
17. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
18. HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis.
Lai PH; Wang WL; Ko CY; Lee YC; Yang WM; Shen TW; Chang WC; Wang JM
Biochim Biophys Acta; 2008 Oct; 1783(10):1803-14. PubMed ID: 18619497
[TBL] [Abstract][Full Text] [Related]
19. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.
Yuan X; Ma R; Yang S; Jiang L; Wang Z; Zhu Z; Li H
Cell Cycle; 2019 Jul; 18(14):1660-1669. PubMed ID: 31204563
[No Abstract] [Full Text] [Related]
20. Imatinib induces demethylation of miR-203 gene: an epigenetic mechanism of anti-tumor effect of imatinib.
Shibuta T; Honda E; Shiotsu H; Tanaka Y; Vellasamy S; Shiratsuchi M; Umemura T
Leuk Res; 2013 Oct; 37(10):1278-86. PubMed ID: 23953880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
